Pages that link to "Q50249006"
Jump to navigation
Jump to search
The following pages link to Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound (Q50249006):
Displaying 50 items.
- Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging (Q21223671) (← links)
- Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain? (Q26783174) (← links)
- Nanoparticle delivery enhancement with acoustically activated microbubbles (Q26866082) (← links)
- The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice (Q28253117) (← links)
- Pharmacokinetic changes induced by focused ultrasound in glioma-bearing rats as measured by dynamic contrast-enhanced MRI (Q28541576) (← links)
- A new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug delivery (Q28543529) (← links)
- Behavioral alterations following blood-brain barrier disruption stimulated by focused ultrasound (Q30372523) (← links)
- Wireless microstimulators for neural prosthetics. (Q30379442) (← links)
- Focused ultrasound-mediated drug delivery through the blood-brain barrier (Q30394357) (← links)
- Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus (Q30394725) (← links)
- Effects of Microbubble Size on Ultrasound-Induced Transdermal Delivery of High-Molecular-Weight Drugs (Q30402483) (← links)
- Sonochemotherapy: from bench to bedside (Q30406257) (← links)
- Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets. (Q30408959) (← links)
- Ultrasound-induced blood-brain barrier opening (Q30437732) (← links)
- In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice (Q30439400) (← links)
- Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo (Q30441135) (← links)
- Dependence of the reversibility of focused- ultrasound-induced blood-brain barrier opening on pressure and pulse length in vivo (Q30441137) (← links)
- Numerical study of a simple transcranial focused ultrasound system applied to blood-brain barrier opening. (Q30441143) (← links)
- Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. (Q30441159) (← links)
- Identifying the inertial cavitation threshold and skull effects in a vessel phantom using focused ultrasound and microbubbles (Q30441162) (← links)
- Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles (Q30443197) (← links)
- Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer's double transgenic mice using focused ultrasound (Q30443217) (← links)
- Optimization of the ultrasound-induced blood-brain barrier opening (Q30458489) (← links)
- Production of uniformly sized serum albumin and dextrose microbubbles (Q30459677) (← links)
- Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol (Q30465348) (← links)
- Feasibility of noninvasive cavitation-guided blood-brain barrier opening using focused ultrasound and microbubbles in nonhuman primates (Q30468434) (← links)
- Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequencies (Q30470999) (← links)
- Comparison between maximum radial expansion of ultrasound contrast agents and experimental postexcitation signal results (Q30471783) (← links)
- Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles. (Q30473728) (← links)
- Contrast‐enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood‐brain barrier with ultrasound (Q30474000) (← links)
- Targeted drug delivery across the blood-brain barrier using ultrasound technique (Q30474781) (← links)
- Determination of postexcitation thresholds for single ultrasound contrast agent microbubbles using double passive cavitation detection (Q30475303) (← links)
- Contrast agent kinetics in the rabbit brain during exposure to therapeutic ultrasound (Q30475367) (← links)
- Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures (Q30475459) (← links)
- Ultrasonic disruption of the blood-brain barrier enables in vivo functional mapping of the mouse barrel field cortex with manganese-enhanced MRI. (Q30475699) (← links)
- Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo (Q30477962) (← links)
- An MRI-compatible system for focused ultrasound experiments in small animal models. (Q30481745) (← links)
- Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering (Q30482585) (← links)
- Challenges for molecular neuroimaging with MRI (Q33680025) (← links)
- Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds (Q37010459) (← links)
- Ultrasound treatment of neurological diseases--current and emerging applications (Q38739505) (← links)
- Improving drug delivery technology for treating neurodegenerative diseases (Q38769989) (← links)
- Effects of biophysical parameters in enhancing radiation responses of prostate tumors with ultrasound-stimulated microbubbles (Q39156541) (← links)
- Longitudinal Motor and Behavioral Assessment of Blood-Brain Barrier Opening with Transcranial Focused Ultrasound (Q42174500) (← links)
- Quantitative guidelines for the prediction of ultrasound contrast agent destruction during injection (Q45363310) (← links)
- Sonoporation, drug delivery, and gene therapy (Q45858068) (← links)
- Delivery of TFPI-2 using SonoVue and adenovirus results in the suppression of thrombosis and arterial re-stenosis (Q45862580) (← links)
- Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning (Q48175287) (← links)
- Targeting Effects on the Volume of the Focused Ultrasound-Induced Blood-Brain Barrier Opening in Nonhuman Primates In Vivo (Q48255390) (← links)
- Cavitation microstreaming and stress fields created by microbubbles (Q48414220) (← links)